Genetic screens in mammalian cells by enhanced retroviral mutagens
- 7 December 2000
- journal article
- Published by Springer Nature in Oncogene
- Vol. 19 (52) , 5964-5972
- https://doi.org/10.1038/sj.onc.1203992
Abstract
Genetic approaches such as retrovirus-mediated mutagenesis and cDNA expression libraries have contributed greatly to our understanding of signal transduction in mammalian cells. However, previously described methods for retroviral insertional mutagenesis are hindered by low mutagenesis rates and difficulties in cloning mutated genes. cDNA expression library methods are usually cell-type dependent and bias towards abundant and short messages. With the near completion of the genome projects, alternative genetic methods are needed where large numbers of genes can be more easily isolated and biochemically studied. We have developed a novel retrovirus-mediated genetic screening method in cultured cells. To achieve efficient and regulated mutagenesis, we constructed Enhanced Retroviral Mutagen (ERM) vectors that contained several engineered sequences (e.g., an ERM Tag and a splice donor) controlled by a tetracycline-responsive promoter. Endogenous genes can thus be randomly activated and tagged in a conditional system. NIH3T3 cells were used to screen for focus-forming genes using the ERM strategy. We showed that these added sequences increased the screening efficiency by >10-fold, and allowed more direct identification of the genes targeted. Sequence analysis of approximately 10% of the >600 focus clones recovered revealed both known oncogenes and novel factors such as protein kinases and GTP/GDP exchange proteins. The ERM strategy should help to facilitate large-scale gene identification in diverse pathways and integrate both genetic (with the completion of the genome projects) and functional information more readily.Keywords
This publication has 48 references indexed in Scilit:
- CD30 in Normal and Neoplastic CellsClinical Immunology, 1999
- Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.Proceedings of the National Academy of Sciences, 1996
- A new strategy of gene trapping in ES cells using 3'RACETransgenic Research, 1995
- Erythropoietin receptor: Cloning strategy and structural featuresThe International Journal of Cell Cloning, 1990
- Targeting of Nonexpressed Genes in Embryonic Stem Cells Via Homologous RecombinationScience, 1989
- Activation of the Cellular Proto-Oncogene Product p21Ras by Addition of a Myristylation SignalScience, 1989
- Selection for Precise Chromosomal Targeting of a Dominant Marker by Homologous RecombinationScience, 1989
- Provirus tagging as an instrument to identify oncogenes and to establish synergism between oncogenesArchiv für die gesamte Virusforschung, 1988
- The Abusable PastRadical History Review, 1987
- Gene Product of v- fgr onc : Hybrid Protein Containing a Portion of Actin and a Tyrosine-Specific Protein KinaseScience, 1984